专利检索 ap:("Takeda Pharmaceutical Company Limited") AND inv:"Adelman, Burt" 第 1 页

1.

发明公开
A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA 审中-公开

公开(公告)号：EP4011916A1

公开(公告)日：2022-06-15

申请号：EP21204197.4

申请日：2016-07-21

申请人： Takeda Pharmaceutical Company Limited

发明人： Mason, Shauna , Kenniston, Jon A. , Nixon, Andrew , Sexton, Daniel J. , Comeau, Stephen R. , Adelman, Burt

IPC分类号： C07K16/36 , A61K39/395

摘要： Disclosed herein are anti-Factor XIIa antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling ( e.g. , hereditary angioedema), and ocular diseases.